Ex-CEO at Chi­na Bi­o­log­ic spear­heads $3.9B buy­out of­fer; Sy­neos ac­quires Ki­napse, adding 600 staffers

Just weeks af­ter Bei­jing-based Chi­na Bi­o­log­ic $CBPO boot­ed its chair­man and CEO David Gao “for cause,” the ex­ec­u­tive has bounced back at …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.